Role of reactive metabolites in the circulation in extrahepatic toxicity - Test2 - elhamkhani - TriplyDB

Role of reactive metabolites in the circulation in extrahepatic toxicity

Role of reactive metabolites in the circulation in extrahepatic toxicity

http://www.wikidata.org/entity/Q26849288

about

Characterizing protein modifications by reactive metabolites using magnetic bead bioreactors and LC-MS/MS Elucidating Organ-Specific Metabolic Toxicity Chemistry from Electrochemiluminescent Enzyme/DNA Arrays and Bioreactor Bead-LC-MS/MS.Potential roles of myeloperoxidase and hypochlorous acid in metabolism and toxicity of alkene hydrocarbons and drug molecules containing olefinic moieties.Prediction of metabolites of epoxidation reaction in MetaTox.Rutin ameliorates oxidative stress and preserves hepatic and renal functions following exposure to cadmium and ethanol.From Classical Toxicology to Tox21: Some Critical Conceptual and Technological Advances in the Molecular Understanding of the Toxic Response Beginning From the Last Quarter of the 20th Century.Effects of co-exposure to atrazine and ethanol on the oxidative damage of kidney and liver in Wistar rats.

P2860

Q35142968-E2282334-85AF-4963-AE7F-930EA88F20B4 Q35190683-68DBA192-9B58-4C37-99B4-F714F071388F Q39034440-CB91F2F5-19E5-4019-A3B1-7CB577828E05 Q47603570-7C9EC0FD-0866-4EF2-9236-5A5857A3CCDD Q47660971-0AE03378-9196-45B3-BE6F-E66F151330ED Q47873443-02BE77F3-1405-4B91-B46D-A6724F8A65CE Q50245416-A4E9787F-99D8-4DF6-AFC5-6DF96CAB4CDC

P2860

Role of reactive metabolites in the circulation in extrahepatic toxicity

http://www.wikidata.org/entity/Q26849288

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Role of reactive metabolites in the circulation in extrahepatic toxicity

@ast

Role of reactive metabolites in the circulation in extrahepatic toxicity

@en

Role of reactive metabolites in the circulation in extrahepatic toxicity

@nl

type

label

Role of reactive metabolites in the circulation in extrahepatic toxicity

@ast

Role of reactive metabolites in the circulation in extrahepatic toxicity

@en

Role of reactive metabolites in the circulation in extrahepatic toxicity

@nl

prefLabel

Role of reactive metabolites in the circulation in extrahepatic toxicity

@ast

Role of reactive metabolites in the circulation in extrahepatic toxicity

@en

Role of reactive metabolites in the circulation in extrahepatic toxicity

@nl

P1433

Q26849288-18312D1C-AEFB-4737-889A-C3661AB9D178

P1476

Q26849288-0D3DDA22-E808-4C37-910E-76AAC16F5598

P2093

Q26849288-90A46E66-DF67-4BB7-8BD0-BB717EC7E65D

Q26849288-EC0EEC62-7CB0-4909-A9E6-0CF5F14F003F

P2860

Q26849288-01549571-3305-4ED8-8D3B-C5224695597C

Q26849288-062BB1BC-4E83-4CF9-A31E-C60487B669B0

Q26849288-0797A423-1BA0-4CC2-929D-402AB12B6F04

Q26849288-12DAC638-7B6C-4C1C-8E0B-412EDA3AE1DC

Q26849288-1A363418-1C2A-4D4E-BD7D-527F29D8C5BE

Q26849288-1D33710A-6E92-4C0A-97A0-FA079D975F33

Q26849288-1E5CE0AF-D7CF-49CA-B92F-6F3860FD56C5

Q26849288-1F4FB7AA-C63D-412A-AE0C-64A82ABA1DE3

Q26849288-1FFF0B8D-7630-42C0-BE5C-507D61C9CE57

Q26849288-23CBE8C8-1FCD-4C9D-8942-CF9B7A30CA43

P304

Q26849288-B60AD496-0EC6-4849-8BEF-368B850FB024

P31

Q26849288-A461CE5B-D3B4-48F0-83A4-9D6C40DF4A03

P356

Q26849288-14C81E60-8B7C-4E0C-94D9-EF0F383CABF9

P407

Q26849288-780C67D0-9367-4079-ACE7-38C0A65015F4

P433

Q26849288-9D15D834-353F-4ACC-B9EB-159BE747CBE6

P478

Q26849288-B9409951-08FB-4A44-80E2-4D35D0BF54AB

P577

Q26849288-5EA65468-55AA-4189-86BB-1463E1ED5897

P698

Q26849288-43AAD656-CB00-43CA-93D5-13DAC06517C6

P932

Q26849288-CB16A4F7-D37B-4CE6-84A2-E7AA477B2DB2

P356

17425255.2012.695347

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Role of reactive metabolites in the circulation in extrahepatic toxicity

@en

P2093

Adnan A Elfarra

http://www.w3.org/2001/XMLSchema#string

Roy M Irving

http://www.w3.org/2001/XMLSchema#string

P2860

Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes

Role of mitochondrial dysfunction in cellular responses to S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells

Timing of new black box warnings and withdrawals for prescription medications

Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression

N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen

Methimazole protection of rats against chemically induced kidney damage in vivo

Differential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomes

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

Cysteine conjugate beta-lyase activity of rat erythrocytes and formation of beta-lyase-derived globin monoadducts and cross-links after in vitro exposure of erythrocytes to S-(1,2-dichlorovinyl)-L-cysteine

Isoform distinct time-, dose-, and castration-dependent alterations in flavin-containing monooxygenase expression in mouse liver after 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.

P304

1157-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2012.695347

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22681489

http://www.w3.org/2001/XMLSchema#string

P932

3423547

http://www.w3.org/2001/XMLSchema#string